Assessing the effects of supplementation with Nutrof® Total on the ability of the eye to filter blue light
Not Applicable
Completed
- Conditions
- Macular pigment, eye health, age related macular degeneration.Eye DiseasesSenile macular degeneration (atrophic)(exudative)
- Registration Number
- ISRCTN79841039
- Lead Sponsor
- Spectrum Thea Pharmaceuticals (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
1. Healthy volunteers recruited from local optometrists
2. Male or female
3. Aged 50 or older
Exclusion Criteria
1. Type 1 and 2 diabetics
2. Pregnancy or intention to become pregnant
3. History of estrogen sensitive cancer
4. Warfarin users
5. Neovascular age-related macular degeneration (AMD) sufferers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Macular pigment optical density (MPOD) will be measured in the patients eye using a Tinsley® MPOD. These readings will be taken at baseline, 21 days, 3 months and 6 months.
- Secondary Outcome Measures
Name Time Method o secondary outcome measures